Table 1.
Baseline characteristics of the balANZ trial participants
| Characteristic | Biocompatible (n=91) | Control (n=91) |
|---|---|---|
| Age (yr) | 59.3±14.20 | 57.9±14.72 |
| Female | 39 (42.9) | 43 (47.3) |
| Ethnicity | ||
| Caucasian | 77 (85) | 69 (76) |
| Aboriginal and Torres Strait Islander | 0 (0) | 2 (2) |
| Asian | 10 (11) | 13 (14) |
| Maori and Pacific Islander | 4 (4) | 7 (7) |
| Cardiovascular disease | 70 (76.1) | 71 (81.6) |
| Diabetic nephropathy | 30 (33.0) | 31 (34.1) |
| Medications | ||
| angiotensin converting enzyme inhibitor | 40 (44.0) | 41 (45.1) |
| angiotensin receptor blocker | 25 (27.5) | 29 (31.9) |
| β-blocker | 45 (49.5) | 51 (56.0) |
| statin | 67 (73.6) | 61 (67.0) |
| aspirin | 40 (44.0) | 46 (50.5) |
| nonsteroidal anti-inflammatory drug | 4 (4.4) | 2 (2.2) |
| anticoagulants | 16 (17.6) | 18 (19.8) |
| diuretics | 40 (44.0) | 46 (50.5) |
| exit-site mupirocin | 29 (31.9) | 36 (39.6) |
| exit-site gentamicin | 0 (0) | 0 (0) |
| Body mass index (kg/m2) | 27.7±5.02 | 28.4±6.16 |
| Systolic BP (mmHg) | ||
| supine | 139.8±21.4 | 138.9±21.8 |
| standing | 134.2±20.7 | 133.3±23.4 |
| Diastolic BP (mmHg) | ||
| supine | 76.6±11.3 | 78.1±11.0 |
| standing | 76.7±11.9 | 78.0±12.7 |
| Hemodialysis before PD | 13 (14.3) | 4 (4.4) |
| Initial PD modality | ||
| continuous ambulatory PD | 81 (89.0) | 82 (90.1) |
| automated PD | 10 (11.0) | 9 (9.9) |
| Prescribed dialysate volume (L/d) | 8 (2–10) | 8 (2–8.7) |
| Dialysate glucose exposure (g/d) | 122±35 | 124±36 |
| GFR (ml/min per 1.73 m2) | 7 (3–18) | 7 (3–18) |
| Urine volume (mL/d) | 1495 (379–3525) | 1365 (455–3359) |
| Weekly peritoneal urea clearance (L/wk per 1.73 m2) | 51.1±10.4 | 52.6±14.5 |
| Weekly peritoneal creatinine clearance (L/wk per 1.73 m2) | 38.3±9.0 | 36.3±11.9 |
| Peritoneal ultrafiltration (ml/d) | 700 (−700 to 3500) | 1090 (−400 to 2800) |
| Dialysate/plasma creatinine ratio at 4 hours (1 mo) | 0.67±0.10 | 0.62±0.10 |
| Normalized protein nitrogen appearance (g/kg/d) | 1.05±0.25 | 1.06±0.26 |
| Serum albumin (g/L) | 37.9±4.8 | 36.9±5.7 |
| Serum total calcium corrected (mmol/L) | 2.4±0.2 | 2.4±0.3 |
| Hemoglobin (g/L) | 115±17 | 115±17 |
Results are presented as number (%), mean ± SD, or median (range).